Mathew Maurer, MD
Dr. Maurer is a general internist and geriatric cardiologist with advanced training in heart failure and cardiac transplantation. He is the Arnold and Arlene Goldstein Professor of Cardiology at Columbia University Irving Medical Center, Vagelos College of Physicians & Surgeons, where directs the Clinical Cardiovascular Research Laboratory for the Elderly (CCRLE).
He has published over 450 articles including peer reviewed manuscripts, reviews and book chapters. He was Chair of the American College of Cardiology’s Geriatric Cardiology Member Section, which is the largest organization dedicated to advancing the care of older adults with cardiovascular disease. He was co-chair of the Steering Committee of the ATTR-ACT trial showing tafamidis was a safe and effective therapy for transthyretin amyloid cardiomyopathy. Throughout his career, he has promulgated an approach to older adults with cardiovascular disease that offers the best of both geriatric and cardiovascular medicine in which a comprehensive holistic approach to enhance functional capacity and quality of life is at the forefront of emerging techniques to address cardiovascular physiologic derangement that disproportionately afflict older adults.
Financial relationships
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:PfizerTopic:AmyloidosisDate added:04/10/2025Date updated:04/10/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:IntelliaTopic:AmylodiosisDate added:04/10/2025Date updated:04/10/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:BridgeBioTopic:AmyloidosisDate added:04/10/2025Date updated:04/10/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:AlnylamTopic:AmyloidosisDate added:04/10/2025Date updated:04/10/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:IonisTopic:AmyloidosisDate added:04/10/2025Date updated:04/10/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:AttralusTopic:AmyloidosisDate added:04/10/2025Date updated:04/10/2025
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:Astra ZenecaTopic:AmyloidosisDate added:04/10/2025Date updated:04/10/2025
**Disclaimer**
This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.

Facebook
X
LinkedIn
Forward